logo
  

Centamin Reports Q3 Total Gold Production Of 93,624 Ounces - Quick Facts

Centamin Plc's(CEY.L,CELTF.PK,CEE.TO) reported preliminary production results from its Sukari Gold Mine in Egypt for the quarter to September 30, 2014.

Total gold production for the quarter reached 93,624 ounces, a 15% increase on the second quarter of 2014 and 10% higher year-over-year. The expanded plant achieved nameplate capacity of 10Mtpa during the quarter, with the potential for throughput rates to increase further during subsequent quarters as the new plant is fully optimized.

Underground and open pit average grades increased over the third quarter and are likely to improve further during the fourth quarter, driving increased gold production levels. Therefore, the firm reiterates its full-year forecast of 420,000 ounces gold.

Open pit total material movement rose 16% sequentially to 11,406kt with the current daily ammonium nitrate issue of 25 tonnes a day.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq. While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
RELATED NEWS
Follow RTT